China Top 10 Human Rabies Antibody Potential Enterprises

July 10, 2024

Human rabies antibody is a crucial treatment for individuals who have been exposed to the rabies virus. This lifesaving therapy works by neutralizing the virus before it can infect the nervous system. Administered through a series of injections, human rabies antibody is highly effective in preventing the onset of rabies symptoms and ultimately saving lives.

Shandong Sinder Technology Co., Ltd.
Zhejiang Tianyuan Bio-Pharmaceutical Co., Ltd.
Changchun BCHT Biotechnology Co., Ltd.
Chengdu Rongsheng Pharmaceutical Co., Ltd.
Wuhan Institute of Biological Products Co., Ltd.
Changchun Zhuoyi Biological Co., Ltd
Hualan Biological Engineering Inc.

Shandong Sinder Technology Co., Ltd.

Establishment time : 2005

website : www.sinder.com

Main Product : Industrial automation equipment, robotics, conveyor systems

Company Profile

Shandong Sinder Technology Co., Ltd. is a leading manufacturer of industrial automation equipment based in China. Founded in 2005, we specialize in providing cutting-edge robotics and conveyor systems to a wide range of industries. With a focus on innovation and customer satisfaction, we have established ourselves as a reliable partner for businesses looking to improve their production processes.

Zhejiang Tianyuan Bio-Pharmaceutical Co., Ltd.

Establishment time : 2002

website : www.tianyuanbio.com

Main Product : Heparin Sodium, Enoxaparin Sodium, Chondroitin Sulfate, etc.

Company Profile

Zhejiang Tianyuan Bio-Pharmaceutical Co., Ltd. is a renowned company specializing in the production of pharmaceutical raw materials and ingredients. Established in 2002, the company has grown to become a leading player in the industry with a wide range of high-quality products such as Heparin Sodium, Enoxaparin Sodium, and Chondroitin Sulfate. With over 1000 employees, the company serves both domestic and international markets, maintaining a strong competitive position in the market. Visit their website at www.tianyuanbio.com for more information.

Changchun BCHT Biotechnology Co., Ltd.

Establishment time : Changchun BCHT Biotechnology Co., Ltd. was founded in 2006.

website : http://www.bchtbio.com/.

Main Product : Their main products include vaccines, diagnostics, and biopharmaceuticals.

Company Profile

Changchun BCHT Biotechnology Co., Ltd. specializes in the development and production of innovative biotechnology products.

Chengdu Rongsheng Pharmaceutical Co., Ltd.

Establishment time : 2002

website : www.rongshengpharma.com

Main Product : Pharmaceutical products

Company Profile

Chengdu Rongsheng Pharmaceutical Co., Ltd. was founded in 2002 and is a medium-sized pharmaceutical company based in Chengdu, China. The company focuses on the production and distribution of a variety of pharmaceutical products, primarily serving the domestic market in China. Despite facing strong competition from other pharmaceutical companies in the region, Rongsheng Pharmaceutical continues to strive for excellence in the industry. Visit their website at www.rongshengpharma.com for more information.

Wuhan Institute of Biological Products Co., Ltd.

Establishment time : Wuhan Institute of Biological Products Co., Ltd. was established in 1967.

website : http://www.whkh.com.cn/.

Main Product : Their main products include vaccines and biological products.

Company Profile

Wuhan Institute of Biological Products Co., Ltd. is a well-established company with a strong presence in the market.

Changchun Zhuoyi Biological Co., Ltd

Establishment time : 2005

website : www1.zhuoyi-bio.com

Main Product : Human Rabies Vaccine,Rabies Prevention ,Freeze-dried Human Rabies Vaccine ,Rabies Vaccine,Human Rabies Vaccination,Human Rabies Vaccine and Infant

Company Profile

Changchun Zhuoyi Biological Co., Ltd., located in Shuangyang Economic Development Zone of Changchun City, is a key vaccine manufacturer invested by Zhejiang SelCorning Biotechnology Co., Ltd. in Jilin Province, and a vice chairman unit of Zhejiang Chamber of Commerce in Jilin Province. The company was founded on January 27, 2005. Mr. Feng Xingfu, chairman and general manager of the company, graduated from the Department of Biology, University of Science and Technology of China, and has been engaged in the marketing and enterprise management of biological products since the 1980s. The company has a registered capital of one hundred and one million six hundred and ninety-two thousand seven hundred and eighty-four yuan, covers an area of 41600 square meters, and has the leading vaccine research and development and production capacity in China. Changchun Zhuoyi Biological Co., Ltd. is a new vaccine manufacturer integrating R&D, production and sales. At present, the biological products approved by the company are mainly Rabies Vaccine (Vero cell) for Human Use, Freeze-dried. The company successfully passed the two in one inspection at the end of 2016 and obtained the registration approval and GMP certificate, which was officially put into production in January 2017. The company's existing production workshop covers an area of about 5700 square meters, with a cumulative investment of 400 million yuan. At present, the maximum annual output is 1 million people. The second phase workshop has been completed at the end of 2018, and will be officially produced in 2020. By then, the production capacity can reach 4 million people. The company has nearly 2000 square meters of pilot scale research workshop, advanced equipment such as bioreactor, ultrafiltration system, AKTA purification workstation, fluorescence microscope, etc., which are used for virus culture, improvement of purification system and identification of recombinant protein. The company has maintained close scientific research cooperation with many scientific research institutions at home and abroad. At present, the company is developing a serum rabies vaccine and a broad-spectrum human papillomavirus vaccine jointly developed with the Institute of Basic Medicine of the Chinese Academy of Medical Sciences. It is planned to cooperate with Murdoch Children's Research Institute in Australia to develop the round vaccine project. At the same time, the company also actively explores the path of internationalization. At present, the company has started to register in the Philippines, Pakistan, Cambodia, Bangladesh, Mongolia, Uzbekistan and other countries. It is estimated that the export of finished products in some markets will be realized by 2020. The company's technical cooperation project with Australia is one of the company's many international cooperation projects. The company always adheres to the concept of "standardized management, quality first", and adheres to the core values of "honesty, diligence, innovation, preciseness, learning and happiness", so as to provide high-quality vaccine products to serve the health of the people.

Hualan Biological Engineering Inc.

Establishment time : Hualan Biological Engineering Inc. was founded in 1992 in China.

website :

Main Product : With a large company size, Hualan Biological Engineering Inc. has a strong presence in both the Chinese and international markets.

Company Profile

Hualan Biological Engineering Inc. continues to expand its product offerings and reach new markets, solidifying its position as a leader in the industry.

Author:

Mr. Simba Li

E-mail:

lixuejian@zy-bio.cn

Phone/WhatsApp:

+86 18946525326